• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Novel LMNA Splice Mutation Induces Aberrant Transcripts in Familial Partial Lipodystrophy

by
November 19, 2026
in Biology
Reading Time: 7 mins read
0
Novel LMNA Splice Mutation Induces Aberrant Transcripts in Familial Partial Lipodystrophy

Novel LMNA Splice Mutation Induces Aberrant Transcripts in Familial Partial Lipodystrophy

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A clinical and functional genetic investigation has demonstrated that a rare heterozygous splice-site mutation in the LMNA gene alters pre-mRNA processing to produce three distinct abnormal transcripts, resulting in severe familial partial lipodystrophy type 2. The study, conducted by medical researchers at Qilu Hospital of Shandong University and Jinan Hospital, evaluated a 21-year-old Chinese woman who presented with marked selective adipose tissue loss alongside profound metabolic abnormalities. Familial partial lipodystrophy type 2, historically known as Dunnigan-type lipodystrophy, is an autosomal dominant condition typically linked to alterations in the LMNA gene, which encodes the essential nuclear structural proteins lamin A and lamin C. Whole-exome sequencing paired with confirmatory Sanger sequencing revealed a single-nucleotide substitution, designated c.1488 + 2T>C, positioned at the conserved donor splice site of intron 8. Through in vitro minigene splicing assays in cultured human embryonic kidney cells, the research team directly established that this single base change destabilizes standard splice-site selection, triggering intron retention, partial exon deletion, and complete exon skipping.

The patient was admitted to the endocrinology department with a established five-year history of polycystic ovary syndrome and newly detected hyperglycemia identified one month prior to evaluation. Physical examination documented a body mass index of 20.44 kilograms per square meter, a height of 167 centimeters, a weight of 57 kilograms, and resting blood pressure measuring 132/85 millimeters of mercury. Clinical inspection revealed pronounced regional subcutaneous fat loss across the peripheral anatomy, manifesting as prominent superficial veins in the extremities and well-defined skeletal musculature over the trunk and lower limbs. Subcutaneous adipose tissue was relatively preserved over the facial contours, neck, and upper torso, while the labia majora exhibited hypertrophy alongside marked prominence of the mons pubis fat pad. This characteristic constellation, recognized clinically as the Dunnigan sign, helped clinicians distinguish her condition from generalized lipodystrophy syndromes. Furthermore, careful physical and diagnostic evaluations confirmed the absence of classical acromegaloid features or Cushingoid hallmarks such as facial plethora, moon facies, or dorsocervical fat accumulation.

To objectively quantify the patient’s body fat distribution, the clinical team performed whole-body dual-energy X-ray absorptiometry using a Hologic Discovery Wi instrument. The scan demonstrated a total body fat mass of 9.99 kilograms, representing 18.6 percent of her total body mass of 53.72 kilograms, with lean soft tissue and bone mineral content accounting for 43.73 kilograms. Although her overall fat percentage remained near the lower threshold of normal reference values for young adult women, regional fat partitioning exhibited a marked disproportion indicative of partial lipodystrophy. Dual-energy absorptiometry measured 4,250 grams of fat within the trunk compared to 3,161 grams distributed across both lower limbs, consisting of 1,641 grams in the left leg and 1,520 grams in the right leg. This yielded a trunk-to-lower-limb fat mass ratio of 1.34, exceeding the established diagnostic threshold of 1.2 used to differentiate familial partial lipodystrophy type 2 from healthy female controls.

Laboratory testing revealed pronounced insulin resistance accompanied by severe metabolic dysregulation and secondary organ involvement. Glycated hemoglobin was elevated at 6.80 percent, accompanied by an average blood glucose level of 8.63 millimoles per liter. A standardized oral glucose tolerance test with simultaneous insulin and C-peptide tracking showed fasting plasma glucose at 7.16 millimoles per liter, peaking at 16.52 millimoles per liter at one hour, and remaining elevated at 16.27 and 13.47 millimoles per liter at two and three hours, respectively. Compensatory hyperinsulinemia was severe, with fasting insulin reaching 81.67 microunits per milliliter and postprandial concentrations surpassing the test measurement ceiling of 300.00 microunits per milliliter across all subsequent post-load intervals. Fasting C-peptide was recorded at 6.70 nanograms per milliliter, rising above 14.00 nanograms per milliliter during the post-challenge phase. Serum lipid analysis showed hypertriglyceridemia at 2.10 millimoles per liter, reduced high-density lipoprotein cholesterol at 0.7 millimoles per liter, and elevated serum uric acid at 456 micromoles per liter. Concurrently, liver enzymes were elevated, with alanine aminotransferase at 92 units per liter, aspartate aminotransferase at 56 units per liter, and gamma-glutamyl transferase at 69 units per liter, while abdominal ultrasound confirmed moderate hepatic steatosis.

Cardiovascular and endocrine evaluations were conducted to delineate the broader clinical scope of the patient’s presentation and exclude secondary etiologies. Echocardiographic evaluation demonstrated a left ventricular ejection fraction of 69 percent alongside mild tricuspid regurgitation. Hormonal evaluations demonstrated elevated serum total testosterone levels of 97.75 nanograms per deciliter, consistent with her history of polycystic ovary syndrome, alongside ultrasound confirmation of bilateral polycystic ovarian morphology. Adrenocorticotropic hormone and cortisol secretion retained their physiological diurnal rhythm, with cortisol decreasing from 15.70 micrograms per deciliter at 8:00 AM to 1.57 micrograms per deciliter at midnight.

Therapeutic management combined targeted pharmacological agents with dietary modifications and structured physical activity. The patient was prescribed combined oral contraception containing 3 milligrams of drospirenone and 0.02 milligrams of ethinyl estradiol to control hyperandrogenic symptoms, while glycemic management relied on 500 milligrams of metformin and 64 milligrams of sitagliptin daily. Dyslipidemia was treated with 200 milligrams of fenofibrate daily, hypertension was managed with 30 milligrams of controlled-release nifedipine daily, and hepatic dysfunction was addressed using 140 milligrams of silibinin three times daily. A registered dietitian prescribed a structured hypocaloric regimen providing approximately 1,400 to 1,600 kilocalories daily, targeting an energy restriction of roughly 25 kilocalories per kilogram daily to diminish ectopic lipid deposition without inducing systemic weight loss. The prescribed macronutrient distribution comprised 50 to 55 percent complex carbohydrates, 20 percent protein, and 25 to 30 percent fat, accompanied by salt restriction below 5 grams daily and regular weekly exercise. Follow-up investigations documented improved glycemic and metabolic control, with fasting blood glucose decreasing to 5.4 millimoles per liter, two-hour postprandial glucose reaching 7.9 millimoles per liter, fasting insulin dropping to 43.2 microunits per milliliter, serum triglycerides stabilizing at 1.3 millimoles per liter, and regular menstrual function returning.

Genetic analysis began with high-throughput whole-exome sequencing performed on peripheral blood genomic DNA from the patient, followed by direct verification using bidirectional Sanger sequencing in the patient and her parents. The whole-exome platform enriched human exonic sequences alongside flanking 20-base-pair intronic boundaries, achieving target coverages of 98.52 percent at ten-fold depth and 97.67 percent at twenty-fold depth, with an overall mean read coverage of 182.73 reads. Sequence alignment against the human reference genome hg19 identified a heterozygous mutation in LMNA, annotated as NM_170707: c.1488 + 2T>C. Sanger sequencing confirmed that neither parent carried the variant allele in peripheral blood DNA, indicating a probable de novo mutation. Computational splice prediction platforms, including BDGP, NetGene2-2.42, and RDDC, concordantly indicated that substituting thymine with cytosine at the second nucleotide of intron 8 would severely impair recognition of the canonical donor splice site. Following standard American College of Medical Genetics and Genomics criteria, the variant was initially designated as a variant of uncertain significance under criteria PVS1_Moderate, PM6, and PM2_Supporting.

To establish the empirical biological impact of the non-canonical splice-site alteration, the investigators developed an in vitro minigene transcription system. Synthetic 108-base-pair DNA fragments encompassing wild-type and mutant exon 8 sequences were cloned into the eukaryotic expression vector pSPL3 across the XhoI and BamHI restriction endonuclease sites. After sequence verification of the recombinant plasmids, wild-type constructs, mutant constructs, and empty vector controls were transfected into HEK293 and HEK293T cells across three independent biological replicates. Total RNA was isolated 48 hours post-transfection, followed by complementary DNA synthesis and polymerase chain reaction amplification using vector-specific forward SD6 and reverse SA2 primers. Agarose gel electrophoresis demonstrated that while cells expressing the wild-type construct generated a single expected product corresponding to normal splicing, cells transfected with the c.1488 + 2T>C mutant construct consistently exhibited three distinct aberrant bands, reflecting profound disruption of transcriptional splicing fidelity.

Subsequent Sanger sequencing of the amplified complementary DNA products resolved the molecular sequences of the three aberrant splice products generated by the mutant allele. The largest abnormal transcript, resolved as a 427-base-pair band, resulted from the retention of 59 base pairs from the 5-prime end of intron 8, formally designated NM_170707.4: c.1488 + 1_1488 + 59ins. This insertion induces a translational frameshift at amino acid position 497, substituting an alanine for isoleucine and introducing a premature termination codon 70 codons downstream, producing a truncated lamin A polypeptide of 496 amino acids instead of the canonical 664 amino acids. The second aberrant transcript, a 359-base-pair band, resulted from the deletion of nine nucleotides from exon 8 (NM_170707.4: c.1480_1488del), which removes three specific amino acids, valine 494 through threonine 496, yielding the protein variant p.Val494_Thr496del. The third aberrant transcript, resolved at 260 base pairs, resulted from complete skipping of exon 8, designated NM_170707.4: c.1381_1488del, leading to an extensive in-frame sequence loss spanning aspartic acid 461 through threonine 496, creating the altered protein p.Asp461_Thr496del.

The structural consequences of these three abnormal isoforms provide a mechanistic basis for the cellular pathology observed in lamin-associated disorders. Lamin A and lamin C proteins assemble into the fibrous nuclear lamina meshwork beneath the inner nuclear membrane, providing structural integrity, supporting chromatin organization, and regulating gene transcription. Exon 8 encodes a critical segment of the central alpha-helical rod domain, which is essential for coiled-coil dimerization and higher-order lamin polymer assembly. These aberrant interactions exert a dominant-negative interference over nuclear lamina architecture, destabilizing the mechanical stability of the nuclear envelope.

The clinical phenotype documented in this patient presents an informative contrast to previous medical literature regarding donor splice variants in LMNA intron 8. The identical c.1488 + 2T>C variant had been identified in 2025 by Shchagina and colleagues in a family whose clinical presentation was dominated by cardiac conduction disease, dilated cardiomyopathy, and limb-girdle muscular dystrophy, with only mild lipodystrophy in a subset of carriers. In contrast, the 21-year-old patient evaluated here exhibited a predominant, severe lipodystrophy phenotype without clinical evidence of cardiomyopathy or skeletal myopathy at presentation. The researchers noted that neighboring mutations at the same donor junction, including c.1488 + 1G>A, c.1488 + 5G>C, and c.1488 + 5G>A, also produce variable mixtures of alternative transcripts, supporting the hypothesis that phenotypic divergence among carriers may reflect the quantitative balance between specific aberrant isoforms and residual wild-type expression.

The study authors highlighted several methodological limitations that frame the interpretation of their findings. Additionally, circulating concentrations of leptin and adiponectin were not measured, skinfold caliper measurements were omitted, and autoimmune serological testing was not performed to exclude rare acquired lipodystrophies. While functional assays demonstrated disrupted splicing in heterologous minigene models, patient-derived endogenous RNA and protein tissues were unavailable to quantify the precise in vivo ratio of aberrant transcripts. Based on the functional validation demonstrating multi-transcript disruption, the variant was reclassified from uncertain significance to likely pathogenic under American College of Medical Genetics criteria, confirming the genetic diagnosis of familial partial lipodystrophy type 2.

Subject of Research: Functional characterization and clinical phenotype of a heterozygous LMNA splice-site mutation in familial partial lipodystrophy type 2

Article Title: Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2

Article References: Chai, M., Zhang, R., Guo, L., Liu, H., Yang, M., Qu, J., Liu, F., Zhai, Y., Wang, W., Zheng, H., Yan, F., & Liu, F. (2026). Identification and functional characterization of the heterozygous LMNA c.1488 + 2T>C splice variant in a Chinese patient with familial partial lipodystrophy type 2. Frontiers in Genetics, 17, Article 1963869. https://doi.org/10.3389/fgene.2026.1963869

Image Credits: AI Generated

DOI: 10.3389/fgene.2026.1963869

Keywords: familial partial lipodystrophy type 2, LMNA gene, splice-site mutation, minigene assay, pre-mRNA splicing, insulin resistance, lamin A/C, whole-exome sequencing, Dunnigan sign, exon skipping, intron retention, dual-energy X-ray absorptiometry, hyperinsulinemia, metabolic syndrome, laminopathies, variant of uncertain significance, Sanger sequencing

News Source: Drew Townsend. (November 19, 2026). Novel LMNA Splice Mutation Induces Aberrant Transcripts in Familial Partial Lipodystrophy. Scienmag.

Tags: dual-energy X-ray absorptiometryDunnigan signexon skippingfamilial partial lipodystrophy type 2hyperinsulinemiainsulin resistanceintron retentionlamin A/ClaminopathiesLMNA genemetabolic syndromeminigene assaypre-mRNA splicingSanger sequencingsplice-site mutationvariant of uncertain significancewhole-exome sequencing
Share12Tweet7Share2ShareShareShare1

Related Posts

Afghan Returnees Face Severe Plant Knowledge Erosion Linked to Forced Expulsion

Afghan Returnees Face Severe Plant Knowledge Erosion Linked to Forced Expulsion

November 19, 2026
Bacillus Velezensis Switches Metabolic Pathways to Survive Graded Sodium Selenite Stress

Bacillus Velezensis Switches Metabolic Pathways to Survive Graded Sodium Selenite Stress

November 19, 2026

Mouse Study Maps Chromatin and Splicing Shifts Driving Sertoli Cell Maturation

November 19, 2026

ERBB4 Upregulation Contributes to Parathyroid Dysfunction in Secondary Hyperparathyroidism

November 19, 2026

POPULAR NEWS

  • Mouse Study Maps Chromatin and Splicing Shifts Driving Sertoli Cell Maturation

    Mouse Study Maps Chromatin and Splicing Shifts Driving Sertoli Cell Maturation

    29 shares
    Share 12 Tweet 7
  • Meta-Analysis Identifies Major Factors Shaping Clinical Healthcare Provider Performance

    29 shares
    Share 12 Tweet 7
  • Layered Double Hydroxide Nanomaterials Advance Targeted Drug Delivery Across Biomedical Applications

    29 shares
    Share 12 Tweet 7
  • Lovastatin and 1-MCP Suppress Scald Genes in Cold-Stored Apples

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pharmacist-Led Electronic Symptom Monitoring Linked to More Collaborations in Breast Cancer

Altered TGF-Beta Receptor Signalling Shifts Cartilage Homeostasis Toward Osteoarthritis Breakdown

Post-Exposure Screening Detects Highest Latent Tuberculosis Rates in Thai Hospital Staff

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.